Bicara awards CFO Jennifer Larson stock option for 285,000 shares at $24.63 each

• Bicara Therapeutics granted CFO Jennifer Larson a non-qualified stock option for 285,000 shares under its 2026 Inducement Plan.
• Exercise price set at USD 24.63 per share, matching the Nasdaq close on Aug. 12, 2026.
• Vesting schedule: 25% on the first anniversary of her start date; remainder in 12 equal quarterly installments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bicara Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608140830PRIMZONEFULLFEED9809918) on August 14, 2026, and is solely responsible for the information contained therein.